Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

9 results
Display

Pancreatic alpha-Cell Dysfunction in Type 2 Diabetes: Old Kids on the Block

Moon JS, Won KC

Type 2 diabetes (T2D) has been known as 'bi-hormonal disorder' since decades ago, the role of glucagon from alpha-cell has languished whereas beta-cell taking center stage. Recently, numerous findings indicate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease

Lee J, Hong SW, Rhee EJ, Lee WY

Non-alcoholic fatty liver disease (NAFLD), one of the most common liver diseases, is caused by the disruption of hepatic lipid homeostasis. It is associated with insulin resistance as seen in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
New Therapeutics for Diabetes Using Incretin Hormone

Oh S

  • KMID: 2259281
  • Korean J Med.
  • 2011 Jun;80(6):625-634.
New therapeutics for type 2 diabetes using incretin hormone were introduced recently. Incretin-based therapies consist of two types: GLP-1 agonists mainly acting on the GLP-1 receptor and dipeptidyl peptidase 4...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Protective Effects of Glucagon Like Peptide-1 on HIT-T15 beta Cell Apoptosis via ER Stress Induced by 2-deoxy-D-glucose

Kim JY, Lee SK, Baik HW, Lee KH, Kim HJ, Park KS, Kim BJ

BACKGROUND: The characteristic feature of pancreatic beta cells is highly developed endoplasmic reticulum (ER) due to a heavy engagement in insulin secretion. The ER serves several important function, including post-translational...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of the combination of metformin and fenofibrate on glucose homeostasis in diabetic Goto-Kakizaki rats

Oh TJ, Shin JY, Kang GH, Park KS, Cho YM

  • KMID: 2154249
  • Exp Mol Med.
  • 2013 Jul;45(7):e30.
Metformin has been reported to increase the expression of the glucagon-like peptide-1 (GLP-1) receptor in pancreatic beta cells in a peroxisome proliferator-activated receptor (PPAR)-alpha-dependent manner. We investigated whether a PPARalpha...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Beta Cells Preservation in Diabetes using GLP-1 and Its Analog

Kim BJ

  • KMID: 2168165
  • Hanyang Med Rev.
  • 2009 May;29(2):140-147.
Diabetes Mellitus is a metabolic disease caused by impaired insulin secretion of pancreatic beta cells and increased insulin resistance of peripheral tissues. In Asian T2DM, progressive loss of beta cells...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Exendin-4 on IRS-2 Expression and Phosphorylation in INS-1 Cells

Kim JH, Kim JW, Jeon SY, Park HS, Ham DS, You YH, Lee SH, Cho JH, Kang MJ, Lee KW, Kwon HS, Yoon KH, Cha BY, Lee KW, Kang SK, Son HY

BACKGROUND: Insulin receptor substrate 2 (IRS-2) is a key regulator of beta cell proliferation and apoptosis. This study was aimed to investigate effect of the glucolipotoxicity on apoptosis in INS-1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Exendin-4 Protects Oxidative Stress-Induced beta-Cell Apoptosis through Reduced JNK and GSK3beta Activity

Kim JY, Lim DM, Moon CI, Jo KJ, Lee SK, Baik HW, Lee KH, Lee KW, Park KY, Kim BJ

Oxidative stress induced by chronic hyperglycemia in type 2 diabetes plays a crucial role in progressive loss of beta-cell mass through beta-cell apoptosis. Glucagon like peptide-1 (GLP-1) has effects on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Microarray Analysis of Thyroid Stimulating Hormone, Insulin-Like Growth Factor-1, and Insulin-Induced Gene Expression in FRTL-5 Thyroid Cells

Lee YJ, Park DJ, Shin CS, Park KS, Kim SY, Lee HK, Park YJ, Cho BY

To determine which genes are regulated by thyroid stimulating hormone (thyrotropin, TSH), insulin and insulin-like growth factor-1 (IGF-1) in the rat thyroid, we used the microarray technology and observed the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr